Neoadjuvant PD-1 blockade in dMMR tumors "could potentially eradicate the need for chemotherapy, radiation, and surgery in ...

A trial by MSK researchers has shown that neoadjuvant treatment with GSK's Jemperli spared 80 percent of patients with dMMR ...

EpiBiologics, a leader in tissue-selective extracellular protein degradation, today presented the first preclinical data on its EpiTAC bispecific antibody degrader of c-Met, a potential first-in-class ...

Personalized Tumor-Specific Amplified DNA Junctions in Peripheral Blood of Patients with High-Grade Gliomas - ...

Researchers have developed a personalized blood test that may offer a faster, less invasive way to track high-grade glioma progression.

Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas, one of the most ...

Mayo Clinic researchers have identified a potential new way to monitor the progression of high-grade gliomas , one of the ...

In 2021, research led by Ryan Flynn, MD, PhD, and his mentor, Nobel laureate Carolyn Bertozzi, PhD, opened a new chapter in biology, characterizing a new kind of player on the cell surface: glycoRNAs.

Breast cancer is becoming increasingly treatable, but in some cases the disease can resurface even decades after a patient ...